Veradigm | MDRX - الربح قبل الضريبة

سعر السهم
4.58
التغيير اليومي
-0.07 -1.40%
شهريا
1.78%
سنويا
7.76%
Q1 التوقعات
4.44




الربح قبل الضريبة تغيير تاريخ
Ambu A/S DKK 153M 3M 2025-12
Amplifon EUR 7.16M 44.39M 2025-09
Cardinal Health USD 598M 214M 2025-09
Centene USD -6.67B 6.42B 2025-09
Charles River Laboratories USD 170.03M 98.62M 2025-09
Cigna USD 2.3B 274M 2025-09
Coloplast 1.79B 236M 2025-12
Convatec Group USD 52M 6.3M 2024-06
CVS Health USD 1.35B 4.84B 2025-12
Diasorin EUR 50.55M 11.9M 2025-09
Elevance Health USD 215M 1.19B 2025-12
General Electric Aerospace USD 2.85B 337M 2025-12
Humana USD 527M 214M 2025-09
IQVIA Holdings USD 6.16B 5.84B 2025-09
Laboratory Of America USD 337M 32.3M 2025-09
Maximus USD 126.27M 25.8M 2025-12
McKesson USD 1.4B 344M 2025-09
Med Life RON 11.88M 28.54M 2025-09
Molina Healthcare USD 234M 142M 2025-09
Omnicell USD 9.7M 750K 2025-09
Oriola-kd EUR 2.2M 7.8M 2025-09
Owens Minor USD 35.71M 5.37M 2025-09
Quest Diagnostics USD 336M 57M 2025-09
Rede D'or Sao Luiz BRL 1.49B 405.65M 2025-12
Siemens Healthineers EUR 736M 6M 2025-06
Sonova Holding CHF 234.3M 159.4M 2025-12
Supermax Corporation Bhd MYR -143.04M 41.22M 2025-09
UnitedHealth USD 3.23B 1.16B 2025-09
Veeva Systems USD 436.85M 14.82M 2025-09
Veradigm USD 35.3M 13.95M 2022-09
Xerox USD 365M 347M 2025-09